Stock Market News
AmrytPharma signs European distribution deal for cholesterol drug
Biopharmaceutical company Amryt Pharma has further expanded the route-to-market for Lojuxta, having signed an exclusive distribution agreement across and Central and Eastern Europe with local outfit GryNumber Health.
Amryt's agreement with GryNumber, a healthcare consultancy and distribution company in the region, covers distribution of Lojuxta in Austria, Croatia, the Czech Repblic, Estonia, Finland, Hungary, Latvia, Lithuania, Poland, Slovakia and Slovenia.
Amryt had previously signed distribution deals for Lojuxta, used to treat a rare life-threatening genetic disorder called homozygous familial hypercholesterolemia (HoFH), across Saudi Arabia and Switzerland.
Dr Joe Wiley, chief executive officer of Amryt Pharma, said, "GryNumber Health has a well-established presence in, and significant experience of, the healthcare markets in Central and Eastern Europe and therefore is an ideal partner for us in the region."
"We are delighted to have signed this exclusive distribution agreement as we look to provide access to Lojuxta to patients suffering from HoFH across our licensed territories," he added.
As of 0840 GMT, shares had dipped 0.30% to 19.94p.
Amryt's agreement with GryNumber, a healthcare consultancy and distribution company in the region, covers distribution of Lojuxta in Austria, Croatia, the Czech Repblic, Estonia, Finland, Hungary, Latvia, Lithuania, Poland, Slovakia and Slovenia.
Amryt had previously signed distribution deals for Lojuxta, used to treat a rare life-threatening genetic disorder called homozygous familial hypercholesterolemia (HoFH), across Saudi Arabia and Switzerland.
Dr Joe Wiley, chief executive officer of Amryt Pharma, said, "GryNumber Health has a well-established presence in, and significant experience of, the healthcare markets in Central and Eastern Europe and therefore is an ideal partner for us in the region."
"We are delighted to have signed this exclusive distribution agreement as we look to provide access to Lojuxta to patients suffering from HoFH across our licensed territories," he added.
As of 0840 GMT, shares had dipped 0.30% to 19.94p.
Related share prices |
---|
Amryt Pharma (AMYT) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price